Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Pediatr Crit Care Med. 2013 Nov;14(9):835–842. doi: 10.1097/PCC.0b013e3182a551c8

Table 2.

Characteristics of 28 day survivors at the time of enrollment in trial of activated protein C for pediatric severe sepsis, stratified by functional outcome

Total Children with Good Functional Outcome
n (%)
Children with Poor Functional Outcome
n (%)
Relative Riska 95% Confidence Interval
Entire Cohort 384 315 (82.0) 69 (18.0)
Gender
 Male 204 165 (80.9) 39 (19.1) Referent
 Female 180 150 (83.3) 30 (16.7) 0.67 0.38, 1.1

Age
 <1 month 24 22 (91.7) 2 (8.3) 0.44 0.06, 2.3
 1 month - <1 year 92 73 (79.4) 19 (20.7) 1.5 0.77, 2.6
 1 – < 5 years 125 104 (83.2) 21 (16.8) Referent
 5 – < 12 years 82 69 (84.2) 13 (15.9) 0.89 0.39, 1.8
 12 – < 18 years 61 47 (77.1) 14 (23.0) 1.5 0.72, 2.7

Ethnicity
 White 259 215 (83.0) 44 (17.0) Referent
 Hispanic 71 52 (73.2) 19 (26.8) 1.9 1.0, 3.0
 African Descent 21 17 (81.0) 4 (19.1) 0.99 0.32, 2.5
 Other (Mixed Racial) 22 21 (95.5) 1 (4.6) 0.28 0.03, 1.8
 Asian (Western & South East)b 11 10 (90.9) 1 (9.1) 0

Immune Status
 Non-compromised 338 283 (83.7) 55 (16.3) Referent
 Compromised 34 23 (67.7) 11 (32.4) 1.9 0.94, 3.3

Source of Infection
 Lung 133 117 (88.0) 16 (12.0) Referent
 Blood 131 105 (80.2) 26 (19.9) 1.8 0.89, 3.2
 Intra-Abdominal 33 23 (69.7) 10 (30.3) 2.4 0.98, 4.5
 CNS 30 22 (73.3) 8 (26.7) 3.3 1.4, 5.6
 Otherc 57 48 (84.2) 9 (15.8) 1.1 0.43, 2.5

Recent Trauma
 No 377 312 (82.8) 65 (17.2) Referent
 Yes 7 3 (42.9) 4 (57.1) 3.9 1.4, 5.4

CPR prior to Enrollment
 No 378 313 (82.8) 64 (17.2) Referent
 Yes 6 2 (33.3) 4 (66.7) 5.1 2.9, 5.7

PRISM IIId
 0 to 9 75 68 (90.7) 7 (9.3) Referent
 10 to 19 186 158 (85.0) 28 (15.1) 1.2 0.47, 2.8
 20 to 29 103 76 (73.8) 27 (26.2) 2.8 1.2, 5.2
 ≥30 20 13 (65.0) 7 (35.0) 4.5 1.6, 8.0

Dysfunctional Organ Systems
 ≤2 77 72 (93.5) 5 (6.5)
 3 108 86 (79.6) 22 (20.4)
 4 101 87 (86.1) 14 (13.9)
 ≥5 98 70 (71.4) 28 (28.6)

Chronic Diseasee
 None 227 187 (82.4) 40 (17.6)
 Cardiac 24 20 (83.3) 4 (16.7)
 Respiratory 24 22 (91.7) 2 (8.3)
 Malignancy 16 10 (62.5) 6 (37.5)
 Neurologic 45 38 (84.4) 7 (15.6)
 Diabetes 4 4 (100%) 0 (0%)
 Congenital Anomaly 43 37 (86.1) 6 (14.0)

Infection Type
 No culture done or culture negative 124 108 (87.1) 16 (12.9)
 Viral 15 14 (93.3) 1 (6.7)
 Fungal 24 20 (83.3) 4 (16.7)
 Bacterial
  pure gram positive 105 83 (79.1) 22 (21.0)
  pure gram negative 77 60 (77.9) 17 (22.1)
  mixed gram 39 30 (76.9) 9 (23.1)

ARDS at Enrollment
 No 323 266 (82.4) 57 (17.7)
 Yes 37 27 (73.0) 10 (27.0)

Recent Surgery
 No 343 280 (81.6) 63 (18.4)
 Yes 41 35 (85.4) 6 (14.6)

Randomized to Receive Activated Protein C
 No 190 159 (83.7) 31 (16.3)
 Yes 194 156 (80.4) 38 (19.6)

Baseline Steroids
 No 234 193 (82.5) 41 (17.5)
 Yes 150 122 (81.3) 28 (18.7)

Prior ICU Admission
 No 379 312 (82.3) 67 (17.7)
 Yes 5 3 (60.0) 2 (40.0)
a

Odds Ratio obtained from multivariate logistic regression model adjusted for frequent outcome

b

9 Asian patients with non-missing data all had ‘good’ functional outcome

c

Includes Cardiac, Gynecologic, Pleural, Urinary Tract, Vascular Catheter, Skin, Head/EENT & Bone/Joint

d

Pediatric Risk of Mortality Score III

e

Does not represent mutually exclusive categories